The total return over the past 12 months is +12.24% vs. +16.94% for the S&P 500. So far it's up -24.84% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +12.24% | (5.38%) | (32.93%) | (14.43%) | N/A | N/A |
| Total Return CAGR | +12.24% | (5.38%) | (32.93%) | (14.43%) | N/A | N/A |
| Revenue CAGR | (7.10%) | +9.63% | +11.48% | +28.05% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (156.82%) | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Tandem Diabetes Care, Inc. (TNDM)
| Year | Start price | End price | TNDM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $21.98 | $16.52 | (24.84%) | +14.51% | (39.35%) |
| 2025 | $36.02 | $21.98 | (38.98%) | +17.72% | (56.70%) |
| 2024 | $29.58 | $36.02 | +21.77% | +24.89% | (3.12%) |
| 2023 | $44.95 | $29.58 | (34.19%) | +26.19% | (60.38%) |
| 2022 | $150.52 | $44.95 | (70.14%) | (18.17%) | (51.97%) |
| 2021 | $95.68 | $150.52 | +57.32% | +28.74% | +28.58% |
| 2020 | $59.61 | $95.68 | +60.51% | +18.37% | +42.14% |
| 2019 | $37.97 | $59.61 | +56.99% | +31.22% | +25.77% |
| 2018 | $2.36 | $37.97 | +1508.90% | (4.56%) | +1513.46% |
| 2017 | $21.50 | $2.36 | (89.02%) | +21.70% | (110.72%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
